US/UK/Canada

Share

Contacts

  • Probi
    Ideongatan 1A, 223 70 Lund
    +46(0)46-286 89 20
    https://www.probi.com
  • Anita Johansen

    Interim CEO & VP R&D


    +46 46 286 89 20
  • Basudha Bhattarai Johansson

    VP HR & Sustainability


    +46 46 286 89 20

    • Quotes

    A lot of virus and bacteria enter the body through the mucous membranes, where a majority of our immune system is located. Therefore, we believe that probiotics can play a vital role as delivery carrier.
    Professor Magnus Johansson
    This joint venture is an important step in our commercial efforts to address new and attractive market niches. Even in these turbulent times we see great opportunities to jointly build a successful business, based on our longstanding relationship and confidence in our respective abilities to create scientific and commercial success.
    Tom Rönnlund, CEO Probi
    “We are very excited about the results showing an opportunity to delay the progression of bone loss by using our probiotics in this healthy population, which potentially may lead to a reduced risk for osteoporosis.”
    Ole Søgaard Andersen, CEO of Probi
    We are very happy to initiate this development program together with a strong global partner in OTC. By combining Probi´s probiotic expertise with the pharma company's development resources and regulatory expertise, we will form a very strong team moving forward together.”
    Ole Søgaard Andersen CEO of Probi
    “We are proud to conclude that our largest clinical trial so far has successfully confirmed earlier clinical results. Interestingly, in subjects that did not experience any viral infection during the study period, there was an activation of the immune system measured already after 2 weeks of Probi Defendum® intake, indicating an alert and resilient immune system.”
    Peter Nählstedt, CEO Probi AB
    “It is extremely exciting to launch the new probiotic line - Probi Select™. Through the integration of Nutraceutix, Probi has established a complete probiotic offering with the Probi Premium, Probi Select and Probi LiveBac ranges. Probi is now a true “One stop shop” for any consumer goods company wanting to drive their position in the probiotic market”
    Niklas Bjärum, President Probi USA and Global Sales & Marketing Probi Group.
    I am very excited about this transforming acquisition. Nutraceutix is an excellent match for us. Probi and Nutraceutix have complementary business models, limited customer overlap and share strong entrepreneurial values. The acquision creates a strong platform to continue the growth story in the US and in the global market.
    Peter Nählstedt
    ”There has been strong growth in the North American and Asian probiotic markets the past few years. We now see a growing interest in Europe too, and our new distribution agreements clearly reflect this positive trend
    Niklas Bjärum, Vice President of Marketing & Sales
    Pick a time period -
    Tags ( Active)

    Probi signs agreement with leading VMS supplier in Canada

    Probi has signed a distribution and supply agreement with Jamieson, the leading Canadian producer of vitamins, minerals and supplements (VMS), for the launch of Probi Digestis® starting in March 2015. Jamieson’s new range of gastrointestinal products, Digestive CareTM, will feature Probi Digestis within the line’s leading product, Daily Relief. Probi has already received its first order valued at MSEK 2.5. Jamieson has produced vitamins and supplements since 1922 by combining strict pharmaceutical standards with natural ingredients. The company is the market leader in Canada, accounting

    Probi Digestis® to be launched on new markets in Asia

    Probi AB, a leading probiotic research and development company from Sweden and DKSH, the leading Market Expansion Services provider with a focus on Asia, signed an agreement for the launch of Probi Digestis® in Hong Kong and Macau. Probi and DKSH have signed a long-term agreement for the branding and launch of Probi’s gastrointestinal health product Probi Digestis®, based on Lactobacillus plantarum 299v, Probi’s clinically documented probiotic strain. The agreement is an expansion of the agreement signed in 2013 between Probi and BiO-LiFE, a Malaysian subsidary of DKSH. The product

    Probi to launch Probi Digestis® in Brazil

    Probi has signed a distribution agreement with Laboratório Daudt, the oldest Brazilian pharmaceutical company with market presence since 130 years. Following registration, Lab. Daudt plans to launch Probi Digestis® during 2015. Probi AB and Lab. Daudt have agreed to launch the Swedish market leading probiotic supplement – Probi Mage® – on the Brazilian market. “Key to success in such a large market is distribution into the most important of the 65 000 pharmacies, along with professional contacts with the gastroenterology specialists. Lab. Daudt have these networks, and this is why

    Probi and Pharmavite expand collaboration in the US and international markets

    Probi and Pharmavite have signed a new long-term agreement for distribution and marketing of Probi´s probiotic products. Under the new agreement Pharmavite will broaden the distribution and expand the Nature Made® range with additional probiotic products from Probi. Pharmavite will also expand it´s probiotic business internationally, among other markets, in the Middle East. Pharmavite launched Probi Digestis® capsules based on Probi’s flagship strain LP299V® in the US market under the Nature Made® brand in 2012 and have accounted for a significant portion of Probi’s growth in the US.

    New study shows that probiotics from Probi can increase iron absorption in women of child-bearing age

    Iron deficiency is one of the most common deficiency diseases in the world and it is estimated that about 30% of Swedish women suffer from iron deficiency. Accordingly, it is vital to increase both iron intake and the absorption of iron from food. In a recently concluded meal study, it was shown that the intake of one of Probi’s bacterial strains, Lactobacillus plantarum DSM 9843, can increase the absorption of iron, which could lead to a reduction in the risk of iron deficiency. Lactobacillus plantarum DSM 9843 (LP299V®) is included in ProViva, GoodBelly and Probi Digestis® and has

    Probi to launch Probi Digestis® in Turkey

    Probi has signed a distribution agreement with Impexia, a pharmaceutical sales and marketing company well established in the Turkish market. Impexia plans to launch Probi Digestis® during Q3, 2014. Turkey is a fast moving economy and has a growing probiotic market with several new players succesfully launching new probiotic products lately. The market is expanding and new brands are growing as the medical community is increasing its appreciation for probiotics. “Impexia is committed  to gain market share in the years to come” says Peter Nählstedt, CEO of  Probi. Mr. Nählstedt adds, “

    Sanofi launches Probi Digestis® in Korea

    Probi has signed a distribution and supply agreement with Sanofi. Following this the Consumer Healthcare divison of Sanofi Korea is making a major launch of Probi´s gut health product, Probi Digestis®starting in April 2014. Probi has already delivered products and received substantial orders for the coming quarters. Sanofi is a leading Healthcare company with more than 100.000 employees worldwide and plays an important role in the global probiotic consumer market. Sanofi’s Consumer Healthcare division in Korea offers diverse vitamins, minerals, and health supplements under the well-

    Probi secures strategic US order

    Probi has secured a major order valued at MSEK 3.6 from the US self-care product company Pharmavite. The order pertains to the dietary supplement Probi Digestis®, which promotes gastrointestinal health. The order is based on strong demand for Probi’s digestive health capsules in US pharmacies and retail stores. The order consisting of a number of part shipments will be delivered during the second and third quarter of 2014. This is one of the largest orders ever received by Probi in the Consumer Healthcare business area. “Our partnership with Pharmavite has been expanded over the past

    Probi extends the collaboration with Health World Australia by the launch of Probi Defendum®

    Probi has signed an extension to the long term distribution agreement with Health World Limited, Australia and New Zealand´s market leading probiotic provider. Health World, being Probi´s first partner in the Consumer Healthcare business has successfully been selling Probi Digestis®for 8 years and Health World will now extend their product offering by adding Probi´s immune product Probi Defendum® to their range.The launch is scheduled for Q1 2014. “We are very happy to broaden the successful long-term collaboration with Health World to also include the Probi Defendum® product. Health

    Probi to launch gut health product in Morocco with Botanic Pharma

    Probi has signed a distribution agreement with Botanic Pharma, based in Casablanca, Morocco for the distribution of Probi´s gut health product, Probi Digestis®. The Product will be launched in Morocco in Q1 2014 under the brandname I.B.S. Probi Digestis®. The gastro intestinal health market in Morocco is growing and sales of today is approximately 35 MEUR. I.B.S. Probi Digestis® will be marketed by Botanic Pharma targeting GPs and Gastroenterologists as well as to consumers via retail drug stores and pharmacies. “Botanic Pharma is a growing health care company in Morocco with a strong

    Probi and BiO-LiFE start probiotic partnership

    PROBI AB, a leading probiotic research and development company from Sweden, and BiO-LiFE, a healthcare company in the fast growing Asian vitamin and dietary supplements category, signed a partnership agreement for the launch of a probiotic product, in Malaysia during the second half of 2013 and with the intention to extend into other countries in South East Asia. PROBI and BiO-LiFE have signed a long term agreement to partner for the branding and launch of PROBI’s Lactobacillus plantarum 299v (Probi Digestis®), a clinically documented probiotic product within the gastrointestinal field.

    Probi to launch gut and immune health products in Belarus with AlenMed under the Probi brand

    Probi has signed a distribution agreement with AlenMed Promotion SIA, based in Riga, Latvia for the distribution of Probi Digestis® and Probi Defendum® in Belarus through their representative office in Belarus from Q1 2014. “AlenMed is an international team of experts in the field of marketing and distribution of medical products in Belarus and in the CIS Region. Currently, the company is closely cooperating with companies such as Merck Serono, Axellus, Cook Medical, Certmedica and Bioclin and is going to be an important partner for Probis expansion in the area in the coming years”, says

    Probi and Viva 5 Corporation form Probiotic Business Development Alliance in North America

    Probi has signed a business development agreement with Viva 5, a US probiotic specialist, granting them license rights within Consumer Healthcare for Probi Digestis®and Probi Defendum®in North America. Probi will work with Viva 5 to further strengthen its commercial position as well as the presence and consumer awareness of the Probi brand in the North American market place. Viva 5 and Probi are already engaged in commercial discussions with select US-based companies. The value of the US probiotic dietary supplements market is approximately USD 900 million. It is a highly fragmented

    Probi to launch gut and immune health products in Taiwan with Alvogen

    Probi has signed a distribution agreement with Alvogen IPCO S.Á.R.L, a multi-national pharmaceutical company. Alvogen plans to launch Probi’s gut and immune health products on the Taiwanese market in Q1 2013.“Alvogen is a multi-national company with offices in over 20 countries with ambitious plans for expansion in Asia. Taiwan is a very important market for Alvogen and we are very pleased that they will launch both our consumer healthcare products”, says Michael Oredsson, CEO of Probi. Probi Digestis® is based on Lactobacillus plantarum 299v, which targets bloating, gas formation and

    Probi and Vifor Pharma sign agreement to launch Probi Digestis® and Probi Defendum® in Switzerland

    Probi has signed a distribution and co-marketing agreement with Vifor Pharma, a company of the Galenica Group, to launch Probi’s gut and immune health products on the Swiss pharmacy and drugstore market. The range will be sold under the Vitafor®umbrella brand and Probi Digestis®and Probi Defendum®product brands. The launch will take place in the fourth quarter of 2012 or the first quarter of 2013 and will be supported by strong consumer advertising and one of Switzerland’s best pharmacy sales forces.Vifor Pharma is one of the most prominent consumer healthcare companies in the Swiss market

    Probi signs agreement with a probiotic leader in India

    Probi has signed a distribution agreement with USV Limited, a leading Indian Pharmaceutical company. USV will launch Vibact IBS based on the probiotic formulation Probi Digestis, in Q4 2012 in the growing Indian market. The agreement reinforces and strengthens Probi's existing presence in the large Indian market.“USV is the best probiotic partner in the consumer healthcare sector in India. We are very pleased to partner with USV and to be able to launch our probiotic formulation Probi Digestis in a market with significant growth potential”, says Michael Oredsson, CEO of Probi. Probi’s

    Breakthrough for Probi in U.S. mass retail and mass drug VMS market

    Probi has signed one of its most signficant dietary supplement agreements to date with Pharmavite, a leader in the US vitamin, minerals and supplement market (VMS). Pharmavite will launch Probi’s gut health capsules containing Lp299v™ at  the beginning of 2012 under the Nature Made®brand – the leading U.S brand in VMS. The agreement is expected to generate between 5 and 10 MSEK in net revenue for Probi in 2012.“This is a major breakthrough for Probi in the U.S., as Pharmavite has an outstanding track-record and Nature Made®brand is the market leader in the U.S. food, drug, mass and club

    There are no items matching the current filter
    There are no more items matching the current filter
    Back to top

    Subscribe

    Media